ICD-10 Coding for Benzodiazepine Abuse(F13.1, F13.10, F13.10B)
Learn about ICD-10 coding for benzodiazepine abuse, including F13.10 and F13.121, with detailed documentation requirements and clinical validation.
Complete code families applicable to Benzodiazepine Abuse
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| F13.10 | Sedative, hypnotic, or anxiolytic abuse, uncomplicated | Use when there is documented abuse of benzodiazepines without dependence. |
|
| F13.121 | Sedative, hypnotic, or anxiolytic abuse with intoxication delirium | Use when abuse leads to delirium. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutBenzodiazepine Abuse
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Benzodiazepine Abuse.
Lack of specificity in substance documentation
Impact
Clinical: Impacts treatment decisions, Regulatory: Non-compliance with coding guidelines, Financial: Potential for denied claims
Mitigation
Always specify the benzodiazepine involved, Link symptoms directly to substance use
Confusing benzodiazepine abuse with long-term prescribed use.
Impact
Reimbursement: Incorrect coding can lead to denied claims., Compliance: Misclassification can result in compliance issues., Data Quality: Affects the accuracy of patient records.
Mitigation
Use F13.10 for abuse and Z79.899 for long-term prescribed use.
Substance specificity
Impact
Failure to document specific benzodiazepine can lead to audit findings.
Mitigation
Implement checklist for documenting substance specifics.